The polyamino‐isoprenyl enhancer NV716 enables the antibacterial activity of two families of multi‐target inhibitors against the ESKAPEE bacterium Enterobacter cloacae

Abstract Gram‐negative bacteria are particularly prone to developing antimicrobial resistance (AMR), as evidenced by the WHO's ESKAPEE list of high‐priority pathogens. One strategy that has increased is the use of antibiotic enhancers, which can re‐empower abandoned or poorly active antibiotics agai...

詳細記述

書誌詳細

主要な著者:	Emma Forest, Jordan Lehoux, Alexandre Guy, Thierry Durand, Stéphane Audebert, Luc Camoin, Christopher D. Spilling, Céline Crauste, Stéphane Canaan, Jean Michel Brunel, Jean‐Michel Bolla, Jean‐François Cavalier
フォーマット:	Artigo
言語:	Inglês
出版事項:	Wiley 2025-06-01
シリーズ:	mLife
主題:	activity based‐protein profiling antibiotic resistance Cyclipostins and Cyclophostin analogs drug enhancers oxadiazolone derivatives
オンライン･アクセス:	https://doi.org/10.1002/mlf2.70014
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!